Form 4: OptimizeRx Executive Reports Stock Transaction
Insider Transaction (Form 4)
Edward Stelmakh, Chief Finance & Strat Officer of OptimizeRx Corp, reported a transaction in 1,381 shares of common stock on August 21, 2026.
Summary
- Tax/exercise-price withholding: disposed of 1,381 Common Stock at $7.71 ($10,648) on August 21, 2026; holds 121,791 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Edward Stelmakh — Officer (Chief Finance & Strat Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-21 | Tax/exercise-price withholding | Common Stock | 1,381 | $8 | $10.6K | 121,791 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-21 | Tax/exercise-price withholding (1,381 shares) |
Keywords
insider transaction, Form 4, OPRX, OptimizeRx Corp, neutral, Edward Stelmakh
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.